BANGALORE, July 20 (Reuters) - Shares of Nucryst Pharmaceuticals Corp. (NCST.O: Quote, Profile, Research) doubled their value on Friday, a day after its antimicrobial cream received approval from U.S. health regulators.
The cream, a formulation of nanocrystalline silver NPI 32101, was previously being studied as a treatment for dermatitis but failed in a mid-stage trial in September 2006, prompting the company to discontinue further studies.
" ...it failed to show statistical significance as an anti-inflammatory (treatment), but we did know its antimicrobial properties prior to that," company spokesman David Wills said by phone.
After the failure of the trial, Nucryst focused on seeking approval for the product as a medical device that acts as a barrier to infection from a broad spectrum of microbes, Willis added.
Before today's gains, Nucryst shares had lost about 80 percent of their value since the failure of the trial.
The company has not determined the timing of the product's launch, Nucryst said in a statement.
Shares of the company were up $2.28 at $4.54 in midday trade, making it the highest percentage gainer on the Nasdaq. (Reporting by Jennifer Robin Raj in Bangalore)
Recent WEDXF News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 09:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2023 09:07:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 12:06:24 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM